Lidocaine suppresses HER2-positive breast cancer cell proliferation by targeting the OGT-CCNL1 axis
Abstract Background HER2-positive breast cancer, known for its heterogeneity and complex molecular mechanisms, poses a significant therapeutic challenge. Lidocaine, a widely used local anesthetic, has recently been identified as a potential anticancer agent. This study investigates the effects of li...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer
2025-12-01
|
| סדרה: | Discover Oncology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1007/s12672-025-04194-4 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
